Vicente Anido, Jr.
2016
In 2016, Vicente Anido, Jr. earned a total compensation of $3.1M as Chief Executive Officer & Chairman of the Board at Aerie Pharmaceuticals, a 22% decrease compared to previous year.
Compensation breakdown
| Bonus | $329,410 |
|---|---|
| Option Awards | $1,785,900 |
| Salary | $549,016 |
| Stock Awards | $418,669 |
| Total | $3,082,995 |
Anido received $1.8M in option awards, accounting for 58% of the total pay in 2016.
Anido also received $329.4K in bonus, $549K in salary and $418.7K in stock awards.
Rankings
In 2016, Vicente Anido, Jr.'s compensation ranked 3,074th out of 14,075 executives tracked by ExecPay. In other words, Anido earned more than 78.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,074 out of 14,075 | 78th |
Division Manufacturing | 1,070 out of 5,489 | 81st |
Major group Chemicals And Allied Products | 314 out of 1,895 | 83rd |
Industry group Drugs | 229 out of 1,538 | 85th |
Industry Biological Products, Except Diagnostic Substances | 49 out of 279 | 82nd |
Source: SEC filing on April 27, 2017.
Anido's colleagues
We found three more compensation records of executives who worked with Vicente Anido, Jr. at Aerie Pharmaceuticals in 2016.
News
Aerie Pharmaceuticals CEO Vicente Anido's 2021 pay rises 4% to $3.8M
April 26, 2022
Aerie Pharmaceuticals CEO Vicente Anido's 2020 pay falls 35% to $3.6M
April 27, 2021
Aerie Pharmaceuticals CEO Vicente Anido's 2019 pay slips 18% to $5.5M
April 24, 2020
Aerie Pharmaceuticals CEO Vicente Anido's 2018 pay falls 33% to $6.8M
April 10, 2019